These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 7473129)

  • 1. [3H]epibatidine labels nicotinic receptors in rat brain: an autoradiographic study.
    Perry DC; Kellar KJ
    J Pharmacol Exp Ther; 1995 Nov; 275(2):1030-4. PubMed ID: 7473129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential agonist inhibition identifies multiple epibatidine binding sites in mouse brain.
    Marks MJ; Smith KW; Collins AC
    J Pharmacol Exp Ther; 1998 Apr; 285(1):377-86. PubMed ID: 9536034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Localization of [3H]nicotine, [3H]cytisine, [3H]epibatidine, and [125I]alpha-bungarotoxin binding sites in the brain of Macaca mulatta.
    Han ZY; Zoli M; Cardona A; Bourgeois JP; Changeux JP; Le Novère N
    J Comp Neurol; 2003 Jun; 461(1):49-60. PubMed ID: 12722104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laminar distribution of nicotinic receptor subtypes in human cerebral cortex as determined by [3H](-)nicotine, [3H]cytisine and [3H]epibatidine in vitro autoradiography.
    Sihver W; Gillberg PG; Nordberg A
    Neuroscience; 1998 Aug; 85(4):1121-33. PubMed ID: 9681951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of (+/-)(-)[3H]epibatidine binding to nicotinic cholinergic receptors in rat and human brain.
    Houghtling RA; Dávila-García MI; Kellar KJ
    Mol Pharmacol; 1995 Aug; 48(2):280-7. PubMed ID: 7651361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a novel nicotinic binding site in mouse brain using [(125)I]-epibatidine.
    Whiteaker P; Jimenez M; McIntosh JM; Collins AC; Marks MJ
    Br J Pharmacol; 2000 Oct; 131(4):729-39. PubMed ID: 11030722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic nicotine administration does not increase nicotinic receptors labeled by [125I]epibatidine in adrenal gland, superior cervical ganglia, pineal or retina.
    Dávila-García MI; Musachio JL; Kellar KJ
    J Neurochem; 2003 Jun; 85(5):1237-46. PubMed ID: 12753083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential regulation of neuronal nicotinic receptor binding sites following chronic nicotine administration.
    Flores CM; Dávila-García MI; Ulrich YM; Kellar KJ
    J Neurochem; 1997 Nov; 69(5):2216-9. PubMed ID: 9349569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deletion of the alpha7, beta2, or beta4 nicotinic receptor subunit genes identifies highly expressed subtypes with relatively low affinity for [3H]epibatidine.
    Marks MJ; Whiteaker P; Collins AC
    Mol Pharmacol; 2006 Sep; 70(3):947-59. PubMed ID: 16728647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epibatidine binding sites and activity in the spinal cord.
    Khan IM; Yaksh TL; Taylor P
    Brain Res; 1997 Apr; 753(2):269-82. PubMed ID: 9125412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-acetylcholine displaceable 3[H]epibatidine binding in the rat brain.
    Plenge P; Mellerup E
    Neurosci Lett; 1998 May; 248(1):65-7. PubMed ID: 9665665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding and functional activity of nicotinic cholinergic receptors in selected rat brain regions are increased following long-term but not short-term nicotine treatment.
    Nguyen HN; Rasmussen BA; Perry DC
    J Neurochem; 2004 Jul; 90(1):40-9. PubMed ID: 15198665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoradiographic comparison of [3H](-)nicotine, [3H]cytisine and [3H]epibatidine binding in relation to vesicular acetylcholine transport sites in the temporal cortex in Alzheimer's disease.
    Sihver W; Gillberg PG; Svensson AL; Nordberg A
    Neuroscience; 1999; 94(3):685-96. PubMed ID: 10579560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [125I]IPH, an epibatidine analog, binds with high affinity to neuronal nicotinic cholinergic receptors.
    Dávila-García MI; Musachio JL; Perry DC; Xiao Y; Horti A; London ED; Dannals RF; Kellar KJ
    J Pharmacol Exp Ther; 1997 Jul; 282(1):445-51. PubMed ID: 9223586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-affinity epibatidine binding of functional, human alpha7-nicotinic acetylcholine receptors stably and heterologously expressed de novo in human SH-EP1 cells.
    Peng JH; Fryer JD; Hurst RS; Schroeder KM; George AA; Morrissy S; Groppi VE; Leonard SS; Lukas RJ
    J Pharmacol Exp Ther; 2005 Apr; 313(1):24-35. PubMed ID: 15590768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Localization of nicotinic cholinergic receptors in rat brain: autoradiographic studies with [3H]cytisine.
    Happe HK; Peters JL; Bergman DA; Murrin LC
    Neuroscience; 1994 Oct; 62(3):929-44. PubMed ID: 7870314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of [(125) I]epibatidine binding and nicotinic agonist-mediated (86) Rb(+) efflux in interpeduncular nucleus and inferior colliculus of beta2 null mutant mice.
    Marks MJ; Whiteaker P; Grady SR; Picciotto MR; McIntosh JM; Collins AC
    J Neurochem; 2002 Jun; 81(5):1102-15. PubMed ID: 12065623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative distribution of nicotinic receptor subtypes during development, adulthood and aging: an autoradiographic study in the rat brain.
    Tribollet E; Bertrand D; Marguerat A; Raggenbass M
    Neuroscience; 2004; 124(2):405-20. PubMed ID: 14980390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo labeling of nicotinic acetylcholine receptors in brain with [3H]epibatidine.
    London ED; Scheffel U; Kimes AS; Kellar KJ
    Eur J Pharmacol; 1995 May; 278(1):R1-2. PubMed ID: 7664806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploratory activity and a conditioned fear response: correlation with cortical and subcortical binding of the alpha4beta2 nicotinic receptor agonist [3H]-epibatidine.
    Sienkiewicz-Jarosz H; Maciejak P; Bidziński A; Szyndler J; Siemiatkowski M; Członkowska A; Lehner M; Płaźnik A
    Pol J Pharmacol; 2003; 55(1):17-23. PubMed ID: 12856821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.